<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">CMV </span>
   <span class="font21">[]. </span>
   <span class="font21">cytomegalovirus </span>
   <span class="font19">viral </span>
   <span class="font16">HCMV </span>
   <span class="font16">infection </span>
   <span class="font16">cell </span>
   <span class="font15">antiviral </span>
   <span class="font15">congenital </span>
   <span class="font15">infections </span>
   <span class="font15">{border-style </span>
   <span class="font14">cells </span>
   <span class="font14">immune </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">human </span>
   <span class="font13">specific </span>
   <span class="font13">DNA </span>
   <span class="font13">latency </span>
   <span class="font13">target </span>
   <span class="font13">gene </span>
   <span class="font13">EGS </span>
   <span class="font13">clinical </span>
   <span class="font13">genome </span>
   <span class="font13">latent </span>
   <span class="font12">drugs </span>
   <span class="font12">including </span>
   <span class="font12">organ </span>
   <span class="font12">proteins </span>
   <span class="font12">vaccine </span>
   <span class="font12">CRISPR/Cas </span>
   <span class="font12">cause </span>
   <span class="font12">early </span>
   <span class="font12">effective </span>
   <span class="font12">host </span>
   <span class="font12">replication </span>
   <span class="font12">treatment </span>
   <span class="font12">used </span>
   <span class="font12">genes </span>
   <span class="font12">infections. </span>
   <span class="font12">natural </span>
   <span class="font12">recipients </span>
   <span class="font12">sequence </span>
   <span class="font12">therapeutic </span>
   <span class="font12">transplant </span>
   <span class="font12">Infect. </span>
   <span class="font12">[,]. </span>
   <span class="font12">diseases </span>
   <span class="font12">expression </span>
   <span class="font12">maribavir </span>
   <span class="font12">new </span>
   <span class="font12">patients </span>
   <span class="font12">protein </span>
   <span class="font12">px; </span>
   <span class="font12">required </span>
   <span class="font12">responses </span>
   <span class="font12">therapy </span>
   <span class="font12">transplantation </span>
   <span class="font12">{font-family </span>
   <span class="font11">ACT </span>
   <span class="font11">MCMV </span>
   <span class="font11">agents </span>
   <span class="font11">capsid </span>
   <span class="font11">central </span>
   <span class="font11">font-size </span>
   <span class="font11">hearing </span>
   <span class="font11">immunity </span>
   <span class="font11">major </span>
   <span class="font11">murine </span>
   <span class="font11">results </span>
   <span class="font11">strategies </span>
   <span class="font11">strategy </span>
   <span class="font11">treat </span>
   <span class="font11">variant </span>
   <span class="font11">HHV-, </span>
   <span class="font11">However, </span>
   <span class="font11">RNA </span>
   <span class="font11">RNase </span>
   <span class="font11">TALENs </span>
   <span class="font11">TCM </span>
   <span class="font11">cells. </span>
   <span class="font11">complex </span>
   <span class="font11">double; </span>
   <span class="font11">drug </span>
   <span class="font11">external </span>
   <span class="font11">guinea </span>
   <span class="font11">hematopoietic </span>
   <span class="font11">infected </span>
   <span class="font11">infection: </span>
   <span class="font11">lytic </span>
   <span class="font11">primary </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">reactivation </span>
   <span class="font11">showed </span>
   <span class="font11">targeting </span>
   <span class="font11">viruses </span>
   <span class="font11">Cytomegalovirus </span>
   <span class="font11">Med. </span>
   <span class="font11">Virol../j.jcv... </span>
   <span class="font11">active </span>
   <span class="font11">approved </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">compared </span>
   <span class="font11">efficacy </span>
   <span class="font11">following </span>
   <span class="font11">guide </span>
   <span class="font11">immediate </span>
   <span class="font11">mRNA </span>
   <span class="font11">nervous </span>
   <span class="font11">phase </span>
   <span class="font11">pig </span>
   <span class="font11">promising </span>
   <span class="font11">shown </span>
   <span class="font11">solid; </span>
   <span class="font11">tegument </span>
   <span class="font11">transcription </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(CMV) </span>
   <span class="font11">Clin </span>
   <span class="font11">Letermovir </span>
   <span class="font11">SOT </span>
   <span class="font11">[,,]. </span>
   <span class="font11">activator-like </span>
   <span class="font11">adoptive </span>
   <span class="font11">al.Letermovir </span>
   <span class="font11">allogeneic </span>
   <span class="font11">and/or </span>
   <span class="font11">anti-HCMV </span>
   <span class="font11">application </span>
   <span class="font11">bold </span>
   <span class="font11">candidate </span>
   <span class="font11">caused </span>
   <span class="font11">cells, </span>
   <span class="font11">courier; </span>
   <span class="font11">demonstrated </span>
   <span class="font11">developed </span>
   <span class="font11">editing </span>
   <span class="font11">effects </span>
   <span class="font11">em; </span>
   <span class="font11">engineered </span>
   <span class="font11">envelope </span>
   <span class="font11">essential </span>
   <span class="font11">function </span>
   <span class="font11">growth </span>
   <span class="font11">healthy </span>
   <span class="font11">hematopoietic-cell </span>
   <span class="font11">higher </span>
   <span class="font11">highly </span>
   <span class="font11">infection, </span>
   <span class="font11">infectionJ. </span>
   <span class="font11">infections, </span>
   <span class="font11">late </span>
   <span class="font11">likely </span>
   <span class="font11">loss </span>
   <span class="font11">low </span>
   <span class="font11">memory </span>
   <span class="font11">mental </span>
   <span class="font11">mortality </span>
   <span class="font11">mutants </span>
   <span class="font11">patients, </span>
   <span class="font11">patients. </span>
   <span class="font11">pentamer </span>
   <span class="font11">plasmids </span>
   <span class="font11">potential </span>
   <span class="font11">precursor </span>
   <span class="font11">prevention </span>
   <span class="font11">problems </span>
   <span class="font11">protection </span>
   <span class="font11">provide </span>
   <span class="font11">pt;} </span>
   <span class="font11">receptor </span>
   <span class="font11">reduction </span>
   <span class="font11">related </span>
   <span class="font11">repeats </span>
   <span class="font11">resistant </span>
   <span class="font11">risk </span>
   <span class="font11">sequences </span>
   <span class="font11">short </span>
   <span class="font11">solid </span>
   <span class="font11">specifically </span>
   <span class="font11">stem </span>
   <span class="font11">systems </span>
   <span class="font11">tool </span>
   <span class="font11">vaccines </span>
   <span class="font11">variants </span>
   <span class="font11">virions </span>
   <span class="font11">weakened </span>
  </p>
 </body>
</html>
